AI Analysis
AI-generated analysis. Always verify with the original filing.
Revenue surged 499% to $124.2K with gross profit turning positive at $102.9K (82.9% margin), but operating loss widened slightly to $14.0M and net loss to $14.8M amid heavy R&D investment.
Key Takeaways
1Revenue increased 499.0% to $124.2K from $20.7K, reflecting transition to higher-volume AI Nose sales from prior COVID test kits.
2Gross profit improved 422.9% to $102.9K from -$31.9K loss due to favorable product mix shift lowering cost of revenues.
3Operating loss rose 1.1% to $14.0M from $13.8M as operating expenses exceeded revenue growth despite efficiencies.
4Cash used in operations decreased to $4.6M from $5.8M, aided by inflows from operating assets and liabilities despite the net loss.
5Free cash flow was -$4.6M after $34.6K capital expenditures, reflecting moderated burn for development activities.